100%(4)4 out of 4 people found this document helpful
This preview shows page 9 - 13 out of 14 pages.
Family history-Another strong risk factor is family history. Those who have a parent, brother or sister with Alzheimer’s are more likely to develop the disease. The risk increases if more than one family member has the illness. When diseases tend to run in families, either heredity (genetics), environmental factors, or both, may play a role (. Alzheimer’s Association, 2019).Genetics-Scientists know genes are involved in Alzheimer’s. Two categories of genes influence whether a person develops a disease: risk genes and deterministic genes. Alzheimer's genes have been found in both categories. It is estimated that less than 1 percent of Alzheimer’s cases are caused by deterministic genes (genes that cause a disease, rather than increase the risk of developing a disease. (. Alzheimer’s Association, 2019).( Bekris, Yu, Bird, & Tsuang, 2010)CONTRIBUTING FACTORS
The diagnosis of AD is based on clinical history, neurological examination, and neuropsychological tests. The methods used are to rule out other diagnoses. •Mental Status Exam•Neuropsychological Testing•Blood Tests•Electroencephalogram (EEG)•Computed Tomography Scan (CT)•Magnetic Resonance Imaging (MRI)•Genetic Testing•The only way to confirm the disease is through autopsy (Alzheimer's Association, 2018). (Kumar, Singh, & Ekavali, 2015) Alzheimer’s Association, 2019).Diagnostic Methods
Namenda- treats moderate to severe Alzheimer’s disease. Primary goal is to decrease symptoms, which could allow some people to maintain certain daily functions a little longer than they would without the medication.These drugs may help reduce some symptoms and help control some behavioral symptoms. The medications are Razadyne (galantamine), Exelon (rivastigmine), and Aricept, donepezil.(Alzheimer’s Association, 2019)Treatment Options:
Coralie, Barbe., Isabelle, Morrone, Wolak-Thierry, Aurore., Moustapha, Drame, Damien Jolly, &Novella, J.,(2015).Impact of Functional alterations on quality of life in patients with Alzheimer’sdisease. 571-576.Bekris, L. M., Yu, C. E., Bird, T. D., & Tsuang, D. W. (2010). Genetics of Alzheimer disease. Journalof geriatric psychiatry and neurology, 23(4), 213–227. doi:10.1177/0891988710383571Alzheimer's Disease & Dementia | Alzheimer's Association. (2019). Retrieved fromdisease_what_is_alzheimers.aspArcangelo, V. P., Peterson, A. M., Wilbur, V. F., & Reinhold, J. A. (2017). Pharmacotherapeutics for